- Wolfe Research initiated coverage of GSK plc
- Rating: Outperform
- Price target: $70
- Issuance date: 2026-10-09
Wolfe Research started coverage of GSK plc (GSK) with an Outperform rating and a $70 price target. The initiation is a positive signal from a new covering analyst.
One free account opens every story complete, the live board, the 30-day calendar, a watchlist and breaking alerts on your phone. No card. The wire stays free to read.